Table 1.
AN patients (N = 8108) | AN controls (N = 32 432) | BN patients (N = 5485) | BN controls (N = 21 940) | USED patients (N = 7166) | USED controls (N = 28 664) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sociodemographic characteristics | |||||||||||||||
N | % | N | % | p | N | % | N | % | p | N | % | N | % | p | |
Age groupa | 1.00 | 1.00 | 1.00 | ||||||||||||
<18 years | 4117 | 50.8 | 16 468 | 50.8 | 836 | 15.2 | 3344 | 15.2 | 3107 | 43.4 | 12 428 | 43.4 | |||
18–30 years | 3605 | 44.5 | 14 420 | 44.5 | 4085 | 74.0 | 16 232 | 74.0 | 3295 | 46.0 | 13 180 | 46.0 | |||
>30 years | 386 | 4.8 | 1544 | 4.8 | 591 | 10.8 | 2364 | 10.8 | 764 | 10.7 | 3056 | 10.7 | |||
Sexa | 1.00 | 1.00 | 1.00 | ||||||||||||
Male | 514 | 6.3 | 2056 | 6.3 | 127 | 2.3 | 508 | 2.3 | 774 | 10.8 | 3096 | 10.8 | |||
Female | 7594 | 93.7 | 30 376 | 93.7 | 5358 | 97.7 | 21 432 | 97.7 | 6392 | 89.2 | 25 568 | 89.2 | |||
Ethnicitya | 1.00 | 1.00 | 1.00 | ||||||||||||
Danish | 7694 | 94.9 | 30 776 | 94.9 | 5188 | 94.6 | 20 752 | 94.6 | 6681 | 93.2 | 26 724 | 93.2 | |||
Immigrant or descendent | 414 | 5.1 | 1656 | 5.1 | 297 | 5.4 | 1188 | 5.4 | 485 | 6.8 | 1940 | 6.8 | |||
Cohabiting status | <0.001 | <0.001 | <0.001 | ||||||||||||
Cohabiting | 1847 | 22.8 | 9574 | 29.5 | 1825 | 33.3 | 11 020 | 50.2 | 1784 | 24.9 | 9891 | 34.5 | |||
Living alone | 2139 | 26.4 | 6390 | 19.7 | 2820 | 51.5 | 7576 | 34.5 | 2270 | 31.7 | 6345 | 22.1 | |||
Under age 18 and living with a caregiver | 4117 | 50.8 | 16 468 | 50.8 | 836 | 15.3 | 3344 | 15.2 | 3107 | 43.4 | 12 428 | 43.4 | |||
Highest achieved education | <0.001 | 0.48 | <0.001 | ||||||||||||
Primary/unknown | 2351 | 29.2 | 9449 | 29.3 | 287 | 5.3 | 1106 | 5.1 | 1821 | 25.5 | 7162 | 25.2 | |||
Lower secondary | 3968 | 49.2 | 15 035 | 46.6 | 2420 | 44.4 | 9857 | 45.3 | 3482 | 48.7 | 12 313 | 43.2 | |||
Upper secondary or higher | 1745 | 21.6 | 7749 | 24.0 | 2744 | 50.3 | 10 806 | 49.6 | 1841 | 25.8 | 8998 | 31.6 | |||
Employment status at the index date | <0.001 | <0.001 | <0.001 | ||||||||||||
Employed | 1179 | 14.5 | 6594 | 20.3 | 1.684 | 30.7 | 8917 | 40.6 | 1258 | 17.6 | 7685 | 26.8 | |||
Unemployed | 675 | 8.3 | 1304 | 4.0 | 701 | 12.8 | 1761 | 8.0 | 921 | 12.9 | 1326 | 4.6 | |||
Other | 6254 | 77.1 | 24 534 | 75.6 | 3100 | 56.5 | 11 262 | 51.3 | 4.987 | 69.6 | 19 653 | 68.6 | |||
Mean | s.d. | Mean | s.d. | p | Mean | s.d. | Mean | s.d. | p | Mean | s.d. | Mean | s.d. | p | |
Age (years)a | 18.8 | 5.7 | 18.8 | 5.7 | 1.00 | 23.0 | 5.7 | 23.0 | 5.7 | 1.00 | 20.3 | 7.2 | 20.3 | 7.2 | 1.00 |
Substance use disorder characteristics | |||||||||||||||
N | % | N | % | p | N | % | N | % | p | N | % | N | % | p | |
Any SUD | 676 | 8.3 | 917 | 2.8 | <0.001 | 602 | 11.0 | 568 | 2.6 | <0.001 | 815 | 11.4 | 791 | 2.8 | <0.001 |
Alcohol abuse/dependence | 305 | 3.8 | 312 | 1.0 | <0.001 | 332 | 6.1 | 249 | 1.1 | <0.001 | 345 | 4.8 | 274 | 1.0 | <0.001 |
Cannabis abuse/dependence | 298 | 3.7 | 453 | 1.4 | <0.001 | 194 | 3.5 | 231 | 1.1 | <0.001 | 394 | 5.5 | 381 | 1.3 | <0.001 |
Hard drug abuse/dependenceb | 299 | 3.7 | 426 | 1.3 | <0.001 | 281 | 5.1 | 275 | 1.3 | <0.001 | 387 | 5.4 | 366 | 1.3 | <0.001 |
Timing of SUD diagnosisc | <0.001 | <0.001 | <0.001 | ||||||||||||
SUD predates ED by more than 1 year | 131 | 19.4 | 155 | 16.9 | 109 | 18.1 | 181 | 31.9 | 195 | 23.9 | 209 | 26.4 | |||
SUD and ED diagnosed within the same year | 144 | 21.3 | 95 | 10.4 | 154 | 25.6 | 51 | 9.0 | 226 | 27.7 | 95 | 12.0 | |||
ED predates SUD by more than 1 year | 401 | 59.3 | 667 | 72.7 | 339 | 56.3 | 336 | 59.2 | 394 | 48.3 | 487 | 61.6 | |||
Mean | s.d. | Mean | s.d. | p | Mean | s.d. | Mean | s.d. | p | Mean | s.d. | Mean | s.d. | p | |
Age at first SUD diagnosis (years) | |||||||||||||||
Alcohol abuse/dependence | 26.6 | 8.1 | 26.1 | 7.7 | 0.48 | 29.1 | 7.6 | 29.3 | 8.0 | 0.74 | 26.6 | 7.7 | 25.9 | 8.1 | 0.31 |
Cannabis abuse/dependence | 22.4 | 5.5 | 21.4 | 5.3 | 0.016 | 23.7 | 5.8 | 24.0 | 6.1 | 0.62 | 22.2 | 5.8 | 21.4 | 5.0 | 0.062 |
Hard drug abuse/dependence | 23.0 | 6.3 | 22.5 | 5.7 | 0.30 | 25.2 | 7.0 | 24.5 | 6.5 | 0.27 | 23.6 | 6.3 | 22.5 | 5.2 | 0.006 |
ICD-10 somatic disorders | |||||||||||||||
N | % | N | % | p | N | % | N | % | p | N | % | N | % | p | |
At least one somatic disorder after the index date | 7408 | 91.4 | 27 491 | 84.8 | <0.001 | 5180 | 94.4 | 19 827 | 90.4 | <0.001 | 6564 | 91.6 | 23 466 | 81.9 | <0.001 |
Infectious diseases (A00-B99) | 950 | 11.7 | 2437 | 7.5 | <0.001 | 710 | 12.9 | 1632 | 7.4 | <0.001 | 810 | 11.3 | 1908 | 6.7 | <0.001 |
Neoplasms (C00-D48) | 675 | 8.3 | 2221 | 6.8 | <0.001 | 594 | 10.8 | 2193 | 10.0 | 0.067 | 518 | 7.2 | 1823 | 6.4 | 0.008 |
Haematological diseases (D50-D89) | 252 | 3.1 | 560 | 1.7 | <0.001 | 164 | 3.0 | 475 | 2.2 | <0.001 | 217 | 3.0 | 433 | 1.5 | <0.001 |
Endocrine diseases (E00-E90) | 1038 | 12.8 | 2177 | 6.7 | <0.001 | 759 | 13.8 | 1854 | 8.5 | <0.001 | 1060 | 14.8 | 1762 | 6.1 | <0.001 |
Neurological diseases (G00-H95) | 1401 | 17.3 | 4256 | 13.1 | <0.001 | 1128 | 20.6 | 3304 | 15.1 | <0.001 | 1395 | 19.5 | 3397 | 11.9 | <0.001 |
Circulatory diseases (I00-I99) | 629 | 7.8 | 1603 | 4.9 | <0.001 | 539 | 9.8 | 1575 | 7.2 | <0.001 | 516 | 7.2 | 1332 | 4.6 | <0.001 |
Respiratory diseases (J00-J99) | 1229 | 15.2 | 3995 | 12.3 | <0.001 | 866 | 15.8 | 2650 | 12.1 | <0.001 | 1135 | 15.8 | 3000 | 10.5 | <0.001 |
Gastrointestinal diseases (K00-K93) | 1940 | 23.9 | 5396 | 16.6 | <0.001 | 1454 | 26.5 | 4122 | 18.8 | <0.001 | 1795 | 25.0 | 4255 | 14.8 | <0.001 |
Dermatological diseases (L00-L99) | 1044 | 12.9 | 2787 | 8.6 | <0.001 | 739 | 13.5 | 2128 | 9.7 | <0.001 | 837 | 11.7 | 2215 | 7.7 | <0.001 |
Musculoskeletal diseases (M00-M99) | 2402 | 29.6 | 7624 | 23.5 | <0.001 | 1732 | 31.6 | 5706 | 26.0 | <0.001 | 2038 | 28.4 | 5924 | 20.7 | <0.001 |
Genitourinary diseases (N00-N99) | 2440 | 30.1 | 7599 | 23.4 | <0.001 | 2063 | 37.6 | 6793 | 31.0 | <0.001 | 2087 | 29.1 | 6114 | 21.3 | <0.001 |
Follow-up | |||||||||||||||
Median | IQR | Median | IQR | p | Median | IQR | Median | IQR | p | Median | IQR | Median | IQR | p | |
Follow-up time (years) | 10.5 | 6.5, 16.1 | 10.6 | 6.5, 16.2 | 0.29 | 12.2 | 7.1, 18.0 | 12.2 | 7.2, 18.1 | 0.51 | 8.6 | 5.4, 13.7 | 8.7 | 5.5, 13.9 | 0.11 |
Mortality | |||||||||||||||
N | % | N | % | p | N | % | N | % | p | N | % | N | % | p | |
Deaths during follow-up | 115 | 1.4 | 114 | 0.4 | <0.001 | 53 | 1.0 | 117 | 0.5 | <0.001 | 126 | 1.8 | 92 | 0.3 | <0.001 |
Mean | s.d. | Mean | s.d. | p | Mean | s.d. | Mean | s.d. | p | Mean | s.d. | Mean | s.d. | p | |
Age at death | 30.1 | 8.5 | 29.9 | 8.3 | 0.83 | 30.7 | 7.7 | 32.7 | 7.5 | 0.12 | 30.9 | 8.7 | 30.2 | 9.7 | 0.57 |
AN, anorexia nervosa; BN, bulimia nervosa; IQR, interquartile range; s.d., standard deviation; SUD, substance use disorder; USED, unspecified eating disorder.
Matching variable.
The hard drugs category includes heroin and other opioids, sedative-hypnotics, cocaine and other stimulants, multiple substances and other psychoactive substances (e.g. hallucinogens, volatile solvents and designer drugs).
The timing of first SUD diagnosis among individuals in the control group was determined from the index date of the eating disorder patients to whom they were matched.